AI assistant
Sending…
Mirum Pharmaceuticals, Inc. — Director's Dealing 2021
Jun 8, 2021
31228_dirs_2021-06-08_eb81fb39-956f-4cd8-b46d-c36f3d2b4006.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Mirum Pharmaceuticals, Inc. (MIRM)
CIK: 0001759425
Period of Report: 2021-06-04
Reporting Person: Brege Laura (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-04 | Stock Option (right to buy) | $16.88 | A | 17000 | Acquired | 2031-06-03 | Common Stock (17000) | Direct |
Footnotes
F1: The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2022 annual stockholder meeting.
More from Mirum Pharmaceuticals, Inc.
Capital/Financing Update
2026
May 18
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 27
Annual Report
2026
Apr 24
M&A Activity
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18